MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS.
D000661:Amphetamine; D000662:Amphetamines; D056486:Chemical and Drug Induced Liver Injury; D006261:Headache; D006402:Hematologic Diseases; D006505:Hepatitis; D006834:Hydrazines; D006973:Hypertension; D007022:Hypotension; D007024:Hypotension, Orthostatic; D007520:Isocarboxazid; D008996:Monoamine Oxidase Inhibitors; D009526:Nialamide; D009896:Optic Atrophy; D010293:Pargyline; D010624:Phenelzine; D013566:Sympathomimetics; D014116:Toxicology; D014191:Tranylcypromine
D000662:Amphetamines; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D013566:Sympathomimetics; D007520:Isocarboxazid; C084776:pheniprazine; D014191:Tranylcypromine; D010293:Pargyline; D000661:Amphetamine; D010624:Phenelzine; D009526:Nialamide
AMPHETAMINE; HEADACHE; HEMATOLOGIC DISEASES; HEPATITIS, TOXIC; HYPERTENSION; HYPOTENSION, ORTHOSTATIC; ISOCARBOXAZID; MONOAMINE OXIDASE INHIBITORS; NIALAMIDE; OPTIC ATROPHY; PARGYLINE; PHENELZINE; PHENIPRAZINE; REVIEW; SYMPATHOMIMETICS; TOXICOLOGIC REPORT; TRANYLCYPROMINE